Is a small lesion in the fat anterior to the psoas muscle below the lower pole of the left kidney shortly after a partial nephrectomy concerning for a metastatic lymph node in a patient with stage 1 Renal Cell Carcinoma (RCC)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

A small lesion in the fat anterior to the psoas muscle below the lower pole of the left kidney shortly after a partial nephrectomy for stage 1 Renal Cell Carcinoma (RCC) is concerning and warrants further evaluation, though it may not necessarily represent metastatic disease. According to the American College of Radiology's 2021 update on post-treatment follow-up and active surveillance of clinically localized renal cell carcinoma 1, radiologic imaging is the most useful component of surveillance, as most relapses and cases of disease progression are identified when patients are asymptomatic.

Key Considerations

  • The location described could represent a reactive lymph node, post-surgical change, or normal anatomic variant rather than metastasis.
  • Stage 1 RCC generally has a low risk of metastasis (less than 10%), making lymph node involvement less likely in this scenario.
  • Several factors should be considered when evaluating this finding, including the lesion's size, enhancement pattern, and whether it was present on pre-operative imaging.

Recommended Approach

  • I recommend obtaining a dedicated MRI with contrast of the abdomen and pelvis to better characterize the lesion, followed by possible biopsy if the imaging features are suspicious.
  • Close surveillance with follow-up imaging in 3-6 months would be appropriate to assess for any changes in size or characteristics.
  • Discussing these findings with a multidisciplinary team including your urologist, radiologist, and possibly an oncologist would help determine the most appropriate management approach, as suggested by the guidelines for follow-up of patients with treated or untreated RCC 1.

From the Research

Concerns for Metastatic Lymph Node

  • A small lesion in the fat anterior to the psoas muscle below the lower pole of the left kidney shortly after a partial nephrectomy may be concerning for a metastatic lymph node in a patient with stage 1 Renal Cell Carcinoma (RCC) 2, 3.
  • The presence of such a lesion could indicate the spread of cancer, which is a common occurrence in patients with RCC, especially in those with a history of partial nephrectomy 4, 5.

Diagnostic Considerations

  • The use of imaging modalities such as FDG PET-CT can help diagnose the recurrence of RCC and identify potential metastatic sites, including lymph nodes 2.
  • However, the accuracy of these imaging modalities may vary, and further evaluation, such as histological examination, may be necessary to confirm the diagnosis 2, 3.

Treatment and Prognosis

  • The treatment and prognosis for patients with metastatic RCC depend on various factors, including the extent of disease, the presence of metastatic sites, and the patient's overall health 6, 4, 5.
  • In some cases, partial nephrectomy may be considered as a cytoreductive procedure to reduce tumor burden and improve patient outcomes 6, 5.
  • However, the decision to perform partial nephrectomy in the setting of metastatic RCC should be made on a case-by-case basis, taking into account the patient's individual circumstances and the potential benefits and risks of the procedure 6, 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Role of FDG PET-CT in recurrent renal cell carcinoma.

Nuclear medicine communications, 2010

Research

Role of partial nephrectomy as cytoreduction in the management of metastatic renal cell carcinoma.

Minerva urologica e nefrologica = The Italian journal of urology and nephrology, 2015

Related Questions

Is a small lesion in the fat anterior to the psoas (musculus psoas) muscle below the lower pole of the left kidney shortly after a partial nephrectomy concerning for a metastatic (mets) lymph node?
What are the treatment options for renal cell cancer?
What is the recommended follow-up and treatment plan for a 68-year-old man with renal cell carcinoma (RCC) status post cryoablation in 2014?
What is the recommended imaging test for a patient with a suspected renal cell carcinoma upon hospital discharge?
What is the recommended initial approach for a 76-year-old man with a 1.6 cm x 1.3 cm left renal lesion consistent with renal cell carcinoma?
Is a small lesion in the fat anterior to the psoas (musculus psoas) muscle below the lower pole of the left kidney shortly after a partial nephrectomy concerning for a metastatic (mets) lymph node?
Why are spaced x-rays recommended over Magnetic Resonance Imaging (MRI) for diagnosing a suspected Salter-Harris fracture of the distal fibular physis in a 14-year-old male with a right lateral ankle injury, particularly for assessing displacement and damage to the Anterior Talofibular Ligament (ATFL) and Calcaneofibular Ligament (CFL)?
Why are spaced x-rays recommended over Magnetic Resonance Imaging (MRI) for diagnosing a suspected Salter-Harris fracture of the distal fibular physis in a 14-year-old male with a right lateral ankle injury?
What is prolonged QT (QT interval)?
Why are spaced x-rays recommended over Magnetic Resonance Imaging (MRI) for diagnosing a suspected Salter-Harris fracture of the distal fibular physis in a 14-year-old male with a right lateral ankle injury, where the growth plate is not visible on x-ray?
Why are spaced x-rays recommended over Magnetic Resonance Imaging (MRI) for diagnosing a suspected Salter-Harris fracture of the distal fibular physis in a 14-year-old male with a right lateral ankle injury, where the growth plate is not visible on x-ray?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.